International Journal of Cardiology
Volume 131, Issue 3 , Pages 421-423 , 24 January 2009

Increased interleukin-13 levels in patients with chronic heart failure

  • Yuki Nishimura

      Affiliations

    • Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
    • ,
  • Teruo Inoue

      Affiliations

    • Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
    • Corresponding Author InformationCorresponding author. 5-1-1 Nabeshima, Saga 849-8501, Japan. Tel.: +81 95 234 3536; fax: +81 95 234 2089.
    • ,
  • Takeaki Nitto

      Affiliations

    • Department of Advanced Heart Research, Saga University Faculty of Medicine, Saga, Japan
    • ,
  • Toshifumi Morooka

      Affiliations

    • Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
    • ,
  • Koichi Node

      Affiliations

    • Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan

Received 16 May 2007 ,Revised 6 July 2007 ,Accepted 7 July 2007.

References 

  1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236–241
  2. Sun M, Chen M, Dawood F, et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation. 2007;115:1398–1407
  3. Janssen SP, Gayan-Ramirez G, Van den Bergh A, et al. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation. 2005;111:996–1005
  4. Wills-Karp M, Lyuimbaz J, Xu X, et al. IL-13: central mediator of allergic asthma. Science. 1998;282:2258–2261
  5. Kolios G, Rooney N, Murphy CT, Robertson DA, Westwick J. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut. 1998;43:56–63
  6. Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol. 2000;164:2585–2591
  7. Kawakami M, Kawakami K, Puri RK. Intratumor administration of interleukin 13 receptor-targeted cytotoxin induces apoptotic cell death in human malignant glioma tumor xenografts. Mol Cancer Ther. 2002;1:999–1007
  8. Jeon, S.G., Lee, C.G., Oh, M.H., Chun, E.Y., Gho, Y.S., Cho, S.H., Kim, J.H., Min, K.U., Kim, Y.Y., Kim, Y.K., Elias, J.A. Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge. J Allergy Clin Immunol in press.
  9. Lee CG, Kang HR, Homer RJ, Chupp G, Elias JA. Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc. 2006;3:418–423
  10. Inoue T, Kato T, Uchida T, et al. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardol. 2005;46:239–245
  11. Inoue T, Komoda H, Nonaka M, Kameda M, Uchida T, Node K. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol. 2007;[Epub ahead of print]

PII: S0167-5273(07)01715-9

doi: 10.1016/j.ijcard.2007.07.128

International Journal of Cardiology
Volume 131, Issue 3 , Pages 421-423 , 24 January 2009

Article Tools

* Image Usage & Resolution